These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4683264)

  • 21. The effects of varying doses of delta 9-tetrahydrocannabinol on the human visual and somatosensory evoked response.
    Lewis EG; Dustman RE; Peters B; Straight RC; Beck EC
    Electroencephalogr Clin Neurophysiol; 1973 Oct; 35(4):347-54. PubMed ID: 4126806
    [No Abstract]   [Full Text] [Related]  

  • 22. 9 -Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat.
    Newman LM; Lutz MP; Gould MH; Domino EF
    Science; 1972 Mar; 175(4025):1022-3. PubMed ID: 5061865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta 9-tetrahydrocannabinol: aversive effects in rat at high doses.
    Elsmore TF; Fletcher GV
    Science; 1972 Feb; 175(4024):911-2. PubMed ID: 5008609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular effects of delta-9-tetrahydrocannabinol in man.
    Weiss JL; Watanabe AM; Lemberger L; Tamarkin NR; Cardon PV
    Clin Pharmacol Ther; 1972; 13(5):671-84. PubMed ID: 4559810
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys.
    Harris RT; Waters W; McLendon D
    Psychopharmacologia; 1974 Jun; 37(1):23-9. PubMed ID: 4413316
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 9 -tetrahydrocannabinol and mescaline on self-stimulation.
    Bailey PT; Pradhan SN
    Neuropharmacology; 1972 Nov; 11(6):831-8. PubMed ID: 4638183
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of delta-9-tetrahydrocannabinol on temporal and auditory discrimination performances of monkeys.
    Elsmore TF
    Psychopharmacologia; 1972; 26(1):62-72. PubMed ID: 4626286
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of synthetic 9 -tetrahydrocannabinol on pregnancy and offspring in the rat.
    Borgen LA; Davis WM; Pace HB
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):480-6. PubMed ID: 5143590
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 32. 9 -Tetrahydrocannabinol: effects of EEG and behavior of rhesus monkeys.
    Martinez JL; Stadnicki SW; Schaeppi UH
    Life Sci I; 1972 Jul; 11(13):643-51. PubMed ID: 4632405
    [No Abstract]   [Full Text] [Related]  

  • 33. Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas.
    Merritt JC; Olsen JL; Armstrong JR; McKinnon SM
    J Pharm Pharmacol; 1981 Jan; 33(1):40-1. PubMed ID: 6114151
    [No Abstract]   [Full Text] [Related]  

  • 34. Respiratory effects of delta-9-tetrahydrocannabinol.
    Bellville JW; Swanson GD; Aqleh KA
    Clin Pharmacol Ther; 1975 May; 17(5):541-8. PubMed ID: 1126111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of delta-9-tetrahydrocannabinol administration on the lipid constituents of rat brain subcellular fractions.
    Sarkar C; Ghosh JJ
    J Neurochem; 1975 Feb; 24(2):381-5. PubMed ID: 1113115
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of delta9-tetrahydrocannabinol on body weight and brain electrolytes in the chicken.
    Abel EL; Cooper CW; Harris LS
    Psychopharmacologia; 1974 Mar; 35(4):335-9. PubMed ID: 4831515
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 38. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 39. Endocrine effects of chronic intraventricular administration of delta9-tetrahydrocannabinol to prepuberal and adult male rats.
    Collu R
    Life Sci; 1976 Jan; 18(2):223-30. PubMed ID: 1256238
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs.
    Stoelting RK; Martz RC; Gartner J; Creasser C; Brown DJ; Forney RB
    Anesthesiology; 1973 Jun; 38(6):521-4. PubMed ID: 4706747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.